role alpha-reductas inhibitor treatment advanc prostat carcinoma everyth biolog prostat concept dht oblig androgen respons normal hyperplast growth select malign transform unknown consist emerg androgen-insensit diseas spectrum biolog evolut cancer capabl tumor depend dht neoplast growth uniqu characterist alpha-reductas inhibitor offer sever potenti action systemat evalu 